EU gives approval to Sanofi bid

first_img French drugmaker Sanofi-Aventis won European Union regulatory approval yesterday for its hostile $18.5bn (£11.7bn) takeover bid for US biotech firm Genzyme, saying the deal would not reduce competition in Europe. Sanofi has offered $69 a share – or $18.5bn – to acquire Genzyme, but the price has been rejected by Genzyme chief executive Henri Termeer as too low. Read This Next’Pose’ Creator Steven Canals on Life After His Groundbreaking Show: ‘I’mThe Wrap’The Boys’ Star Aya Cash Took Inspiration From YouTube, TikTok and SteveThe WrapHow HGTV’s ‘Renovation Island’ Changed Bryan and Sarah Baeumler’sThe Wrap’Bridgerton’ Stars Phoebe Dynevor and Nicola Coughlan on Daphne andThe WrapBest Wine Gifts & Wine Accessories at Every PriceGayot’Hitman’s Bodyguard’s Wife’ Earns $17 Million 5-Day Opening as Box OfficeThe WrapFox News’ Mark Levin Says Capitol Riot Suspects ‘Would Be Treated Better’The WrapEverything We Know, or Think We Know, About the Time-Keepers on ‘Loki’The Wrap’The Crown’: What Went Into Finding Princess Diana and Margaret ThatcherThe Wrap Tags: NULL Wednesday 12 January 2011 7:58 pm whatsapp Show Comments ▼ Share whatsapp EU gives approval to Sanofi bid KCS-content last_img

Leave a Reply

Your email address will not be published. Required fields are marked *